SCHEDULE: First Light Asset Management Discloses TriSalus Stake

First Light Asset Management, LLC and Mathew P. Arens have jointly filed a Schedule 13G, reporting beneficial ownership of 10.74% of TriSalus Life Sciences, Inc. common stock as of June 30, 2026.

Summary

• First Light Asset Management, LLC and Mathew P. Arens have jointly filed an amended Schedule 13G, indicating their beneficial ownership of 6,596,242 shares of TriSalus Life Sciences, Inc. common stock.
• This ownership stake represents 10.74% of the total class of securities.
• The filing is made pursuant to Rule 13d-1(b) of the Securities Exchange Act of 1934.
• First Light Asset Management, LLC acts as an investment adviser to accounts that hold these shares and to certain private funds.
• Mathew P. Arens controls First Light Asset Management, LLC as its managing member and majority owner.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of beneficial ownership and does not contain operational or financial performance updates.

Positives

• First Light Asset Management, LLC and Mathew P. Arens have established a significant beneficial ownership stake of 10.74% in TriSalus Life Sciences, Inc.
• The joint filing indicates a coordinated approach to their investment in the company.

Risks

• The filing does not contain specific forward-looking statements or risk factors beyond the standard disclosures associated with a Schedule 13G filing.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company. It is a disclosure of beneficial ownership.

Management Comments

• The Manager may be deemed to be the beneficial owner of these shares because it acts as an investment adviser to certain private funds.
• Mr. Arens may also be deemed to be the beneficial owner of these shares because he controls the Manager in his position as managing member and majority owner of the Manager.
• The filing of this Schedule 13G shall not be construed as an admission that the reporting persons or any of their affiliates are the beneficial owner of any securities covered by this Schedule 13G for any other purposes other than Section 13(d) of the Securities Exchange Act of 1934.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by First Light Asset Management, LLC and Mathew P. Arens signifies a substantial investment in TriSalus Life Sciences, Inc., potentially indicating a belief in the company's future prospects or a strategic positioning within the life sciences sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an investment manager may influence market perception and potentially attract further investor interest or scrutiny.

Next Steps

• The reporting persons will continue to hold and manage their investment in TriSalus Life Sciences, Inc. according to their investment strategies.

Key Dates

Keywords

Schedule 13G, TriSalus Life Sciences, First Light Asset Management, Mathew P. Arens, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing